You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies

Full name:
anti-Kallikrein B, Plasma 1 Antibodies (KLKB1)
On are 17 Kallikrein B, Plasma 1 (KLKB1) Antibodies from 3 different suppliers available. A total of 19 Kallikrein B, Plasma 1 products are currently listed.
Aps, hK3, Kal-3, Kal3, Kalp1, KALP15, KLK2A1, Klk3, PSA
list all antibodies Gene Name GeneID UniProt
KLKB1 16621 P26262
KLKB1 25048  
KLKB1 354 P07288

Show all species

Show all synonyms

Most Popular Reactivities for anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

anti-Human Antibodies:

All available anti-Kallikrein B, Plasma 1 Antibodies

Go to our pre-filtered search.

More Antibodies against Kallikrein B, Plasma 1 Interaction Partners

Mouse (Murine) Kallikrein B, Plasma 1 (KLKB1) interaction partners

  1. Klkb1(-/-) mice have a novel mechanism for thrombosis protection in addition to reduced contact activation. This pathway arises when bradykinin delivery to vasculature is compromised and mediated by increased receptor Mas (show MAS1 Antibodies), prostacyclin, Sirt1 (show SIRT1 Antibodies), and KLF4 (show KLF4 Antibodies)

  2. Plasma kallikrein deletion prevents occlusive thrombus formation in mice with a minimal role in provoked bleeding.

  3. PKK (show RIPK4 Antibodies) or fXII (show F12 Antibodies) deficiency reduced thrombus formation in both arterial and venous thrombosis models, without an apparent effect on hemostasis.

  4. Data suggest that LGG secreting PSA (show NPEPPS Antibodies) may activate antigen specific immune responses when instilled intravesically and IL15 (show IL15 Antibodies) could enhance this response.

  5. the prekallikrein gene (Klkb1) is expressed highly in the mammary gland during stromal remodeling periods including puberty and postlactational involution.

Human Kallikrein B, Plasma 1 (KLKB1) interaction partners

  1. BMI should be taken into consideration when referring men to a prostate biopsy based on serum PSA (show PLAG1 Antibodies)-levels.

  2. Ad5 (show PSEN2 Antibodies)/35E1aPSESE4 is effective in marking PSA (show PLAG1 Antibodies)/PSMA (show FOLH1 Antibodies)-positive prostate cancer cells in patient blood to improve the efficacy of utilizing CTCs as a biomarker.

  3. The synthesis and serum levels of PSA (show PLAG1 Antibodies) are directly affected by prostate tumor cell miR (show MLXIP Antibodies)-183.

  4. Prostate cancer gene 3 gene expression discriminates LN metastasis and might outperform prostate specific antigen (show KLK3 Antibodies) gene activity in reflecting tumor cell burden in pelvic LNs of PCa (show FLVCR1 Antibodies) patients.

  5. detection of prostate cancer and according to PSA (show PLAG1 Antibodies) screening to distinguish men with prostate cancer from men with benign prostatic hyperplasia.

  6. Of those patients who took AA with food at PSA (show PLAG1 Antibodies) progression, a PSA (show PLAG1 Antibodies) decline was observed in 3 of the 19 (16%) men, including 3 of the 14 men who had an initial response to AA (21%).

  7. Testing of four kallikrein (show KLK4 Antibodies) markers in men with an elevated PSA (show PLAG1 Antibodies) could aid biopsy decision making in screening for lethal prostate cancer.

  8. PSA (show PLAG1 Antibodies) expression is highly homogenous in primary prostate cancer.

  9. The analysis based on correlation of MIC-1 (show C18orf8 Antibodies) and PSA (show PLAG1 Antibodies) concentrations in serum with the patient PCa (show FLVCR1 Antibodies) status improved the specificity of Prostate cancer diagnosis

  10. Overexpression of the novel senescence marker GLB1 (show GLB1 Antibodies) in prostate cancer predicts reduced recurrence of PSA (show PLAG1 Antibodies)-expressing tumors.

Kallikrein B, Plasma 1 (KLKB1) Antigen Profile

Antigen Summary

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its protein product is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. Serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms.

Alternative names and synonyms associated with Kallikrein B, Plasma 1 (KLKB1)

  • kallikrein B, plasma 1 (Klkb1) antibody
  • kallikrein-related peptidase 3 (KLK3) antibody
  • SH2B adaptor protein 2 (Sh2b2) antibody
  • Aps antibody
  • hK3 antibody
  • Kal-3 antibody
  • Kal3 antibody
  • Kalp1 antibody
  • KALP15 antibody
  • KLK2A1 antibody
  • Klk3 antibody
  • PSA antibody

Protein level used designations for KLKB1

antigen, prostate specific , fletcher factor , kallikrein 3, plasma , kininogenin , plasma kallikrein , plasma prekallikrein , P-30 antigen , gamma-seminoprotein , kallikrein-3 , prostate specific antigen , prostate-specific antigen , semenogelase , seminin , SH2 and PH domain-containing adapter protein APS , SH2B adapter protein 2 , adapter protein with pleckstrin homology and Src homology 2 domains , adaptor protein with pleckstrin homology and src homology 2 domains

16621 Mus musculus
25048 Rattus norvegicus
354 Homo sapiens
114203 Rattus norvegicus
Selected quality suppliers for anti-Kallikrein B, Plasma 1 (KLKB1) Antibodies
Did you look for something else?